Accumulation of amyloid β and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 9, 1999, Pages 982-992

  Smith, Douglas H ^a   Chen, X H ^a   Nonaka, M ^a   Trojanowski, J Q ^a   Lee, V M Y ^a   Saatman, K E ^a   Leoni, M J ^a   Xu, B N ^a   Wolf, J A ^a   Meaney, D F ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer disease; Amyloid precursor protein; Amyloid ; Brain trauma; Neurodegeneration; Neurofilament Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; NEUROFILAMENT PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; IMMUNOHISTOCHEMISTRY; NEUROFILAMENT; NONHUMAN; PATHOGENESIS; PERIKARYON; PRIORITY JOURNAL; PROTEIN ANALYSIS; SWINE;

EID: 0032860822     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199909000-00008     Document Type: Article

References (75)

1. Sosin DM, Sacks JJ, Smith SM. Head injury-associated deaths in the United States from 1979 to 1986. JAMA 1989;262:2251-55
2. Sosin DM, Sniezek JE, Waxweiler RJ. Trends in death associated with traumatic brain injury, 1979 through 1992. JAMA 1995;273: 1778-80
3. Tokuda T, Ikeda S, Yanagisawa N, Ihara Y, Glenner GG. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein. Acta Neuropathol 1991;82:281-85
4. Roberts GW, Allsop D, Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatry 1990;53:373-78
5. Roberts GW, Gentleman SM, Lynch A, Graham DI. βA4 amyloid protein deposition in brain after head trauma. Lancet 1991;338: 1422-23
6. Graham DI, Gentleman SM, Lynch A, Roberts GW. Distribution of β-amyloid protein in the brain following severe head injury. Neuropath Appl Neurobiol 1995;21:27-34
7. Stuss DT, Stethem LL, Picton TW, Leech EE, Pelchat G. Traumatic brain injury, aging and reaction time. Can J Neurol Sci 1989;16: 161-67
8. Corkin S, Rosen JT, Sullivan EV, Clegg RA. Penetrating head injury in young adulthood exacerbates cognitive decline in later years. J Neurosci 1989;9:3876-83
9. Mortimer JA, Van Duijn CM, Chandra L, et al. Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20:S28-S35
10. Rasmusson DX, Brandt J, Martin DB, Folstein MF. Head injury as a risk factor in Alzheimer's disease. Brain Inj 1995;3:213-19
11. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury and apolipoprotein-∈4 in patients with Alzheimer's disease. Neurology 1995;45:555-57
12. Smith DH, Chen X-H, Pierce JES, et al. Progressive atrophy and neuronal death for one year following brain trauma in the rat. J Neurotrauma 1997;14(10):715-27
13. Bramlett HM, Dietrich WD, Green EJ, Busto R. Chronic histopathological consequences of fluid-percussion brain injury in rats: Effects of post-traumatic hypothermia. Acta Neuropathol 1997;93: 190-99
14. Murai H, Pierce JES, Raghupathi R, et al. Two-fold overexpression of human β-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury. J Comp Neurol 1998;392:428-38
15. Pierce JES, Trojanowski JQ, Graham DI, Smith DH, McIntosh TK. Immunohistochemical characterization of alterations in the distribution of amyloid percursor proteins and amyloid β peptide following experimental brain injury in the rat. J Neurosci 1996;16:1083-90
16. Lewen A, Li GL, Nilsson P, Olsson Y, Hillered L. Traumatic brain injury in rat produces changes of β-amyloid precursor protein immunoreactivity. NeuroReport 1995;6:357-60
17. Sherriff FE, Bridges LR, Sivaloganathan S. Early detection of axonal injury after human head trauma using immunocytochemistry for β-amyloid precursor protein. Acta Neuropathol 1994;87:55-62
18. Bramlett HM, Kraydieh S, Green EJ, Dietrich WD. Temporal and regional patterns of axonal damage following traumatic brain injury: A beta-amyloid precursor protein immunocytochemical study in rats. J Neuropathol Exp Neurol 1997;56:1132-41
19. Smith DH, Nakamura M, McIntosh TK, et al. Brain trauma induces massive hippocampal neuron death linked to a surge in β-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am J Pathol 1998;153:1005-110
20. Smith DH, Chen X-H, Xu B-N, McIntosh TK, Gennarelli TA, Meaney DF. Characterization of diffuse axonal pathology and selective hippocampal damage following inertial brain trauma in the pig. J Neuropathol Exp Neurol 1997;56:822-34
21. Kimura H, Meaney DF, McGowan JC, et al. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: Characterization by magnetization transfer ratio with histopathologic correlation. J Computer Assisted Tomography 1996;20:540-46
22. Meaney DF, Thibault LE, Smith DH, Ross DT, Gennarelli TA. Diffuse axonal injury in the miniature pig: Biomechanical development and injury threshold. ASME WAM 1993;25:169-75
23. Stephenson DT, Clemens JA. In vivo effects of beta-amyloid implants in rodents: Lack of potentiation of damage associated with transient global forebrain ischemia. Brain Res 1992;586:235-46
24. Games D, Khan KM, Soriano FG, et al. Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol. Aging 1992;13:569-76
25. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995;373:523-27
26. Raby CA, Morganti-Kossmann MC, Kossmann T, et al. Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. J Neurochem 1998;71:2505-9
27. Chen X-H, Xu B-N, Meaney DF, et al. Evolution of neurofilament subtype accumulation in axons following diffuse brain injury in the pig. J Neuropathol Exp Neurol 1999;58:588-96
28. Nakagawa Y, Nakamura M, McIntosh TK, et al. Traumatic brain injury in young PDAPP transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Aβ deposition during aging. J Comp Neuro 1999 (in press)
29. Wisniewski H, Terry RD, Hirano A. Neurofibrillary pathology. J Neuropathol Exp Neurol 1970;29:163-76
30. Kidd M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 1963;197:192-93
31. Clark CM, Ewbank D, Lee VM-Y, Trojanowski JQ. Molecular pathology of Alzheimer's disease: Neuronal cytoskeletal abnormalities. In: Growdon J, Rossor M, eds. Blue books of practical neurobiology: The dementias. Boston: Butterworth Heinemann, 1998: 285-304
32. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S. Markers of axonal injury in post mortem human brain. J Neuropath 1994;88:433-39
33. Gultekin SH, Smith TW. Diffuse axonal injury in craniocerebral trauma. A comparative histologic and immunohistochemical study. Arch Pathol Lab Med 1994;118:168-71
34. Smith MA, Siedlak SL, Richey PL, et al. Tau protein directly interacts with the amyloid β-protein precurosor: Implications for Alzheimer's disease. Nature Med 1995;1:365-69
35. Caputo CB, Sygowski LA, Scott CW, Sobel IRE. Role of tau in the polymerization of peptides from β-amyloid precursor protein. Brain Res 1992;597:227-32
36. Hoshino S, Tamaoka A, Takahashi M, et al. Emergence of immunoreactivities for phosphorylated tau and amyloid-beta protein in chronic stage of fluid percussion in rat brain. NeuroReport 1998;9: 1879-83
37. Grady MS, McLaughlin MR, Christman CW, Valadka AB, Fligner CL, Povlishock JT. The use of antibodies targeted against the neurofilament subunits for the detection of diffuse axonal injury in humans. J Neuropathol Exp Neurol 1993;52:143-52
38. Povlishock JT, Christman CW. Diffuse axonal injury. In: Waxman SG, Kocsis JD, Stys PK, eds. The axon: Structure, function and pathophysiology. New York: Oxford University Press, 1995:504-29
39. Trojanowski JQ, Goedert M, Iwatsubo T, Lee VM-Y. Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differentiation 1998;5:832-37
40. Goldman JE, Yen SH. Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann Neurol 1986;19:209-23
41. Trojanowski JQ, Lee VMY. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementia. Ann NY Acad Sci 1994;747:92-109
42. Kanayama G, Takeda M, Morihara T, et al. Temporal and regional profiles of cytoskeletal protein accumulation in the rat brain following traumatic brain injury. Psychiatry Clin Neurosci 1997;51:157-65
43. Nakamura M, Saatman KE, Calvin JE, et al. Increased vulnerability of NFH-LacZ transgenic mouse to traumatic brain injury-induced behavioral deficits and cell loss. J Cereb Blood Flow Metab 1999;762-70
44. Buxbaum JD, Gandy SE, Cicchetti P, et al. Processing of Alzheimer β/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci 1990;87:6003-6
45. Gandy SE, Bhasin R, Ramabhadran TV, et al. Alzheimer β/A4-amyloid precursor protein: Evidence for putative amyloidogenic fragment. J Neurochem 1992;58:383-86
46. Kang J, Lemaire H-G, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-36
47. Hilbich C, Monning U, Grand C, Masters CL, Beyreuther K. Amyloid-like properties of flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22c11. J Biol Chem 1993;268:26571-77
48. Weidemann A, Konig G, Bunke D, et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989;57:115-26
49. Pierce JES, Smith DH, Trojanowski JQ, McIntosh TK. Enduring cognitive, neurobehavioral, and histopathological changes persist for up to one year following severe experimental brain injury in rats. Neurosci 1998;87:359-69
50. Cai. X.-D., Golde TE, Youngkin SG. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 1993;259:514-16
51. Szendrei GI, Prammer KV, Vaski M, Lee VMY, Otvos L, Jr. The effects of aspartic acid-bond isomeritization on in vitro properties of the amyloid beta peptide as modeled with N-terminal decapeptide fragments. Int J Pept Protein Res 1996;47:289-96
52. Schmidt ML, DiDario AG, Otvos L, Jr., et al. Plaque-associated neuronal proteins: A recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Exp Neurol 1994;130:311-22
53. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 1994;13:45-53
54. 717) mutants. Science 1994;264:1336-40
55. Prittila T, Kim KS, Mehta PD, Frey H, Wisniewski HM. Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls. J Neurol Sci 1994;127:90-95
56. Kim KS, Miller DL, Sapienza VJ, et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Comm 1988;2:121-30
57. Kim KS, Wen GY, Bancher C, et al. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci Res Comm 1990;7:113-22
58. Hyman BT, Tanzi RE, Marzloff K, Harbour R, Schenk D. Kunitz protease inhibitor-containing amyloid beta protein precurosr immunoreactivity in Alzheimer's disease. J Neuropathol Exp Neurol 1992;51:76-83
59. Frenkel D, Balass M, Solomon B. N-terminal EFRH sequences of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies. J Neuroimmunol 1998;88:85-90
60. Papasozomenos SC, Binder LI. Phosphorylation determines two distinct species of tau in the central nervous system. Cell Motil Cytoskeleton 1987;8:210-26
61. Papasozomenos SC. Tau protein immunoreactivity in dementia of the Alzheimer's type I. Morphology, evolution, distribution and pathogenic implication.Lab Invest 1989;60:123-37
62. Papasozomenos SC. Tau protein immunoreactivity in dementia of the Alzheimer's type II. Electron microscopy and pathogeneic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments. Lab Invest 1989;60:375-89
63. Greenberg SG, Davies P. A preparation of Alzheimer-paired helical filaments that displays disinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 1990;87:5827-31
64. 396 in Alzheimer's disease recapitulates phosphorylation during development and contributes to reduced microtubule binding. Neuron 1993;10: 1089-99
65. Greenberg SG, Davies P, Schein JD, Binder LI. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992;267:564-69
66. Lang E, Szendrei GI, Lee VMY, Otvos L. Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease. Biochem Biophys Res Commun 1992;187:783-90
67. Mawal-Dewan MY, Henley J, Van de Voorde A, Trojanowski JQ, Lee VM. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J Biol Chem 1994;269:30981-87
68. Reed LA, Schmidt ML, Wszolek ZK, et al. The neuropathology of a chromosome 17-linked autosomal dominant Parkinsonism and dementia ("pallido-ponto-nigral degeneration"). J Neuropathol Exp Neurol 1998;57:588-601
69. Hoffmann R, Lee VM, Leight S, Varga I, Otvos L, Jr. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochem 1997;36:8114-24
70. Shaw G, Osborn M, Weber K. Reactivity of a panel of neurofilament antibodies on phosphorylated and dephosphorylated neurofilaments. Eur J Cell Biol 1986;42:1-9
71. Debus E, Weber K, Osborn M. Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides. Differentiation 1983;25:193-203
72. Shaw G, Winialski L, Reier P. The effect of axotomy and deafferentation on phosphorylation-dependent antigenicity of neurofilaments in rat superior cervical ganglion neurons. Brain Res 1988;460:227-34
73. Gotow T, Tanaka J. Phosphorylation of neurofilament H subunit as related to arrangement of neurofilaments. J Neurosci Res 1994;37:673
74. Harris J, Ayyub C, Shaw G. A molecular dissection of the carboxyterminal tails of the major neurofilament subunits NF-H. J Neurosci Res 1991;30:47-62
75. Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 1997;48:128-32